Author:
Letyagin V. P,Vysotskaya I. V,Grigor’eva T. A
Abstract
The paper examines the main issues of integrated treatment of resectable breast cancer. Identifies underlying prognostic factors and the relation between the choice of systemic therapy on the molecular characteristics of tumours. In the evolutionary aspect different approaches, both local and systemic treatments of patients with resectable primary breast cancer are assessed.
Reference48 articles.
1. Globocan 2008. bttp: // globocan.iarc.fr/ factsbeets/cancers/ breast.asp
2. Давыдов М.И., Аксель Е.М., ред. Статистика злокачественных новообразований в России и странах СНГ в 2010 г. М.; 2012.
3. Autier P. et al. Breast cancer mortality in neigbbouring European countries with different levels of screening but similar access to treatment: treand analysis of WHO mortality database Br. Med. J. 2011; 343: d 4411.
4. Давыдов М.И., Летягин В.П. Клиническая маммология (практическое руководство). М.: АБВ-пресс; 2010: 73—6.
5. Вишнякова В.В. Эффективность экономных операций при раке молочной железы. Вопросы онколгии. 1990; 36(5): 540—5.